AP1724A - Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination - Google Patents

Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination

Info

Publication number
AP1724A
AP1724A AP2005003378A AP2005003378A AP1724A AP 1724 A AP1724 A AP 1724A AP 2005003378 A AP2005003378 A AP 2005003378A AP 2005003378 A AP2005003378 A AP 2005003378A AP 1724 A AP1724 A AP 1724A
Authority
AP
ARIPO
Prior art keywords
freeze dried
vibrio cholerae
safety features
dried form
biological safety
Prior art date
Application number
AP2005003378A
Other languages
English (en)
Other versions
AP2005003378A0 (en
Inventor
Gomez Javier Campos
Hernandez Tomas Marcel Moreira
Gonzalez Boris Luis Rodriguez
Original Assignee
Cnic Ct Nac Investigaciones
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CU20030039A external-priority patent/CU23209A1/es
Priority claimed from CU20030084A external-priority patent/CU23206A1/es
Application filed by Cnic Ct Nac Investigaciones filed Critical Cnic Ct Nac Investigaciones
Publication of AP2005003378A0 publication Critical patent/AP2005003378A0/xx
Application granted granted Critical
Publication of AP1724A publication Critical patent/AP1724A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AP2005003378A 2003-02-20 2004-02-19 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination AP1724A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU20030039A CU23209A1 (es) 2003-02-20 2003-02-20 Candidatos vacunales vivos con indices mejorados de seguridad ambiental para inmunizar oralmente contra el colera
CU20030084A CU23206A1 (es) 2003-04-17 2003-04-17 Formulaciones para liofilizacion de vacunas vivas atenuadas de vibrio cholerae mejoradas en su seguridad ambiental
PCT/CU2004/000002 WO2004073736A1 (es) 2003-02-20 2004-02-19 Cepas atenuadas de vibrio cholerae y vacunas liofilizadas que las contienen

Publications (2)

Publication Number Publication Date
AP2005003378A0 AP2005003378A0 (en) 2005-09-30
AP1724A true AP1724A (en) 2007-02-23

Family

ID=40203010

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003378A AP1724A (en) 2003-02-20 2004-02-19 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination

Country Status (16)

Country Link
US (1) US7592171B2 (de)
EP (1) EP1614426B1 (de)
JP (1) JP4495143B2 (de)
CN (1) CN100569286C (de)
AP (1) AP1724A (de)
AT (1) ATE417625T1 (de)
BR (1) BRPI0407668A (de)
CA (1) CA2516581C (de)
DE (1) DE602004018478D1 (de)
DK (1) DK1614426T3 (de)
EC (1) ECSP055971A (de)
ES (1) ES2319527T3 (de)
MX (1) MXPA05008774A (de)
OA (1) OA13033A (de)
RU (1) RU2316587C2 (de)
WO (1) WO2004073736A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325494D0 (en) * 2003-10-31 2003-12-03 Sbl Vaccin Ab Expression system
US20060233837A1 (en) * 2005-04-19 2006-10-19 Gomez Javier C Vibrio cholerae vaccine candidates, the methods of their constructing and medicinal preparations derived thereof
DK2148923T3 (da) * 2007-05-18 2012-12-03 Medimmune Llc Konservering af biologisk aktive materialer med frysetørret skum
CN101880640B (zh) * 2010-02-09 2013-05-29 北京万特尔生物制药有限公司 肺炎克雷伯氏菌(甘露糖敏感血凝)菌毛株
CN101914463B (zh) * 2010-02-09 2012-09-05 北京万特尔生物制药有限公司 普通变形菌(甘露糖敏感血凝)菌毛株
CU24188B1 (es) * 2012-12-27 2016-07-29 Ct De Ingeniería Genética Y Biotecnología Composición vacunal contra el virus dengue
WO2016113322A1 (en) * 2015-01-14 2016-07-21 Centre National De La Recherche Scientifique Genetically modified vibrio cholerae strains and uses thereof
WO2019014462A1 (en) * 2017-07-12 2019-01-17 The Brigham And Women's Hospital, Inc. LIVING VACCINE ATTENUATED AGAINST CHOLERA WITH PROBIOTIC PROPERTIES
CN110184241B (zh) * 2019-05-14 2021-01-26 菲吉乐科(南京)生物科技有限公司 耐高温溶藻弧菌噬菌体及其组合物、试剂盒和应用
CN111004759B (zh) * 2020-01-04 2023-04-07 广东环凯生物科技有限公司 一种霍乱弧菌的稳定剂及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999005548A1 (fr) * 1997-07-25 1999-02-04 Mitsubishi Rayon Co., Ltd. Fibre optique de type a profil d'indice de refraction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
CU22847A1 (es) * 1998-10-22 2003-04-28 Cnic Ct Nac Investigaciones Conservación de formulaciones vacunales de vibrio cholerae

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999005548A1 (fr) * 1997-07-25 1999-02-04 Mitsubishi Rayon Co., Ltd. Fibre optique de type a profil d'indice de refraction

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EHARA M. ET AL.: 'Characterization of filamentous phages of Vibrio cholerae O139 and O1' FEMS MICROBIOLOGY LETTERS vol. 154, no. 2, 15 September 1997, pages 293 - 301 *
JOURAVLEVA E.A. ET AL.: 'The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for filamentous bacteriophage from V. cholerae O139' INFECTION AND IMMUNITY vol. 66, no. 6, June 1998, pages 2535 - 2539 *

Also Published As

Publication number Publication date
US7592171B2 (en) 2009-09-22
RU2005125793A (ru) 2006-05-27
WO2004073736A1 (es) 2004-09-02
WO2004073736A8 (es) 2005-11-17
CN1780640A (zh) 2006-05-31
ES2319527T3 (es) 2009-05-08
ECSP055971A (es) 2006-01-16
OA13033A (en) 2006-11-10
EP1614426B1 (de) 2008-12-17
ATE417625T1 (de) 2009-01-15
JP4495143B2 (ja) 2010-06-30
DE602004018478D1 (de) 2009-01-29
JP2006518196A (ja) 2006-08-10
CN100569286C (zh) 2009-12-16
RU2316587C2 (ru) 2008-02-10
US20070071775A1 (en) 2007-03-29
CA2516581C (en) 2012-05-15
BRPI0407668A (pt) 2006-03-01
AP2005003378A0 (en) 2005-09-30
CA2516581A1 (en) 2004-09-02
EP1614426A1 (de) 2006-01-11
DK1614426T3 (da) 2009-04-06
MXPA05008774A (es) 2006-02-22

Similar Documents

Publication Publication Date Title
IL223141A0 (en) Immunogenic composition for use in vaccination against staphylococcei
HK1127044A1 (en) Process for the preparation of asenapine and intermediate products used in said process
EP1948232A4 (de) Virale genprodukte und verfahren zur schutzimpfung vor viruserkrankungen
EP1948810A4 (de) Zusammensetzung und verfahren zur effizienten verabreichung von nukleinsäuren in zellen mithilfe von chitosan
IL210916A (en) Clonidine and medicinal products containing it for the prevention or treatment of mucosal inflammation
PL2105129T3 (pl) Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt
GB2479680B (en) Refuge chamber and method
SG2009050212A (en) Severe acute respiratory syndrome dna vaccine compositions and methods of use
IL175373A0 (en) The use of anti biotics as vaccine adjuvants
EP1663222A4 (de) Verfahren im zusammenhang mit der behandlung von schleimhauterkrankungen
EP2083843A4 (de) Multifunktionelle träger zur verabreichung von nukleinsäuren und verwendungsverfahren dafür
AP1724A (en) Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
GB0901481D0 (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
IL204821A (en) An in vitro method for obtaining activated cells displaying antigens used to prepare cancer vaccines
ZA200901993B (en) Novel neutralizing immunogen (NIMIV) of rhinovirus and its use for vaccine applicants
IL174325A0 (en) Dna vaccine compositions and methods of use
HK1125041A1 (en) Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation
ZA200607132B (en) Method of vaccination against testicular BVDV infection
GB0619816D0 (en) Novel interferon-alpha constructs for use in the treatment of cancer
EP1592409A4 (de) Verwendung von essbarer säure in schnell dispergierenden pharmazeutischen festen dosierformen
EP1620126A4 (de) Prävention von erkrankungen und vakzination vor thymus-reaktivierungen
IL177276A0 (en) Method for delivering drugs to tissue under microject propulsion
GB0401036D0 (en) Improvements in or relating to vaccination
EP2061506A4 (de) Impfstoff-zusammensetzung und immunisierungsverfahren
HK1096609A1 (en) Pharmaceutical composition for treating gastric disease containing antiulcerent and mucosal protective agents